Two senior executives of Yuheng pharmaceutical resigned on the same day

On April 20, Yuheng pharmaceutical announced that its company had received written resignations from Mr Li Guochun, director, deputy general manager and Mr Wang Yu, supervisor on the same day On April 19, 2019, the board of directors of Harbin Yuheng Pharmaceutical Co., Ltd (hereinafter referred to as "the company") received a written resignation from Mr Li Guochun, the director and deputy general manager of the company For personal reasons, Mr Li Guochun applied to resign from the position of director and deputy general manager of the company After resignation, Mr Li Guochun no longer holds any position in the company On the same day, the board of supervisors of the company received the written resignation submitted by Mr Wang Yu, the supervisor of the company Mr Wang Yu applied to resign as a supervisor of the company due to the internal job adjustment of the company After resignation, Mr Wang Yu continued to serve as the senior assistant to the chairman of the company, the director of the securities investment center, the executive director and general manager of Shenzhen Yuheng Investment Co., Ltd., a wholly-owned subsidiary of the company According to the company law, the articles of association and other relevant regulations of Yuheng pharmaceutical, the resignation application of Mr Li Guochun and Mr Wang Yu takes effect when it is delivered to the board of directors and the board of supervisors of the company According to the announcement, as of the announcement date, Mr Wang Yu holds 205400 shares of the company Mr Wang Yu promised that the shares of Yuheng Pharmaceutical Co., Ltd held by him will be managed in strict accordance with relevant laws and regulations, such as the guidelines for the standardized operation of listed companies on the SME Board of Shenzhen Stock Exchange, some provisions on the reduction of shares held by major shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange, detailed rules for the implementation of the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange, etc In addition, during the term of office determined at the time of taking office and within six months after the expiration of the term of office, the following restrictive provisions shall continue to be observed: 1 The shares transferred each year shall not exceed 25% of the total shares of the company held by me; 2 Within half a year after leaving office, I shall not transfer the shares of the company held by me; 3 Other provisions of the company law on the transfer of shares of directors, supervisors and senior executives.